Showing results (191-200 of 941) with videos related to
Sort By:
Pageof 95
Neurology and Therapy|April 10, 2025
Monthly Headaches and Severity in Patients on Galcanezumab or Traditional Preventive Migraine Medication: A 24-Month Claims and Electronic Health Records StudyOralee J Varnado, Michelle Vu, Gilwan Kim, et al.Neurology and Therapy|April 10, 2025
Impact of Natalizumab on Productivity and Ability to Work in Patients with Multiple Sclerosis in France: The TITAN StudyPatrick Vermersch, Arnaud Kwiatkowski, Jérôme de Sèze, et al.Neurology and Therapy|June 8, 2023
Multicentre Observational Study of Treatment Satisfaction with Cladribine Tablets in the Management of Relapsing Multiple Sclerosis in the Arabian Gulf: The CLUE StudyJihad Inshasi, Samar Farouk, Ahmed Shatila, et al.Neurology and Therapy|February 18, 2026
Reducing Early-Life Smoke Exposure as a Preventive Strategy for Pediatric Multiple Sclerosis: Results from the PEDIGREE StudySilvy Pilotto, Angelo Ghezzi, Stefania Maria Bova, et al.Neurology and Therapy|March 4, 2026
Efficacy and Safety of Vutrisiran in Patients with Hereditary Transthyretin-mediated Amyloidosis with Polyneuropathy: Analysis of the East Asian Subpopulation from HELIOS-AJeeyoung Oh, Yoshiki Sekijima, Hideki Mochizuki, et al.Neurology and Therapy|June 3, 2023
Ischemic Stroke and Cerebral Microbleeds: A Two-Sample Bidirectional Mendelian Randomization StudyRenjie Liu, Xin Shi, Jiahui Feng, et al.Neurology and Therapy|June 2, 2023
Otogenic Cerebral Sinus Thrombosis in Children: A Narrative ReviewMichal Kotowski, Jaroslaw SzydlowskiNeurology and Therapy|February 26, 2026
Management of Duchenne Muscular Dystrophy in Clinical Practice: A Survey-Based Study in SpainCarlos Ortez, María Branas-Pampillón, Joaquín Alejandro Fernandez, et al.Neurology and Therapy|March 14, 2026
From Environment to Symptoms: Mapping Premorbid Risk Factors onto Clinical Features of ALS in a Patient-Reported Database in ChinaXinyu Li, Qianrui Chen, Dongsheng Fan, et al.Neurology and Therapy|March 9, 2026
Divergent Immunological and Neurotrophic Responses to CD20 Depletion in Relapsing and Progressive Multiple SclerosisGudrun M Körner, Thiemo M Möllenkamp, Konstantin F Jendretzky, et al.Pageof 95